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Abstract 
Introduction: Stillbirth is the loss of a foetus after 22 weeks of gestation, of which almost 
half go completely unexplained despite post-mortem. We recently sequenced 35 arrhythmia-
associated genes from 70 unexplained stillbirth cases. Our hypothesis was that deleterious 
mutations in channelopathy genes may have a functional effect in utero that may be pro-
arrhythmic in the developing foetus. We observed four heterozygous, nonsynonymous 
variants in TRPM7, a ubiquitously expressed ion channel known to regulate cardiac 
development and repolarisation in mice.  
Methods: We used site-directed mutagenesis and single-cell patch-clamp to analyse the 
functional effect of the four stillbirth mutants on TRPM7 ion channel function in heterologous 
cells. We also used cardiomyocytes derived from human pluripotent stem cells to model the 
contribution of TRPM7 to action potential morphology.  
Results: Our results show that two TRPM7 variants, p.G179V and p.T860M lead to a 
marked reduction in ion channel conductance. This observation was underpinned by a lack 
of measurable TRPM7 protein expression, which in the case of p.T860M was due to rapid 
proteasomal degradation. We also report that human hiPSC-derived cardiomyocytes 
possess measurable TRPM7 currents, however siRNA knockdown did not directly affect 
action potential morphology.  
Conclusion: TRPM7 variants found in the unexplained stillbirth population adversely affect 
ion channel function and this may precipitate fatal arrhythmia in utero.  
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Introduction 
Stillbirth is the devastating loss of a foetus after 22 weeks of gestation during pregnancy. 
In the UK, there were 4.64 stillbirths per 1000 total births in 2013 (1). The majority of these 
are caused by obstetric complications, placental insufficiency, genetic disorders, infection 
and umbilical cord anomalies. However, despite extensive post-mortem investigation, 15-
45% of stillbirths go completely unexplained (1-3).  
Deleterious mutations within ion channel genes can cause severe arrhythmias and are 
known causes of sudden death in young adults (4). The cause of death is usually found after 
a negative post-mortem. We recently sequenced a custom panel of 35 arrhythmia-
associated genes in 70 unexplained stillbirth cases from the Cardiac Ion Channelopathies in 
Stillbirth (CICUS) study (5).  We found four cases to have putative pathogenic variants in 
four long QT syndrome (LQTS) genes, KCNE1, KCNE2, SCN5A and KCNJ2.  We 
subsequently characterised the functional effect of the heterozygous variant (p.R40Q) found 
in the KCNJ2 gene. This gene encodes the inwardly rectifying potassium channel Kir2.1 
which controls the resting membrane potential and contributes to cardiac repolarisation 
(Phase 3)(6). The p.R40Q mutation led to significantly reduced inward currents compared to 
wild-type channels, which would be predicted to have a deleterious effect on the 
cardiomyocytes ability to regulate its’ membrane voltage. Alongside these data, we observed 
predicted damaging variants in several other genes, including TRPM7 a gene implicated 
from genome wide association studies of QT interval (7). Four heterozygous 
nonsynonymous variants were observed in TRPM7 in four individual cases.  
Transient receptor potential melastatin 7 (TRPM7) is a non-selective cation channel with 
a serine/threonine kinase domain in the C-terminus and is ubiquitously expressed in 
mammalian cells (8). Current opinion regards TRPM7 as a key transporter of divalent 
cations (Zn2+, Mg2+ and Ca2+) across the cell membrane (9, 10); while the α-kinase is 
capable of phosphorylating downstream effector kinases and modifying chromatin (11, 12). 
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TRPM7 plays a key role in dictating cell proliferation, survival, apoptosis alongside 
organogenesis and embryonic survival (13-16). A previously reported genetic variant, 
p.T1482I, has been shown to increase the sensitivity of TRPM7 to inhibition by Mg2+ (17). 
Temporal control of TRPM7 expression in the mouse embryo is required for correct cardiac 
development (15). 
The four nonsynonymous variants in TRPM7 lie within conserved amino acid 
positions and were predicted to functionally affect the protein by at least one of three 
predicted software tools (PolyPhen, SIFT or Mutation Taster (18, 19)). The first two, 
p.G179V and p.R494Q lie within the N-terminal domain of TRPM7. The third, p.T860M is 
within the second transmembrane domain, whilst the final variant, p.E1205G resides in the 
C-terminal domain, upstream of the alpha kinase (Table 1). 
 In this study we transfect a TRPM7 expressing plasmid into HEK293 and CHO-K1 
cells and record the resulting current using whole-cell patch-clamp electrophysiology. We 
demonstrate that three TRPM7 variants (p.G179V, p.R494Q and p.T860M) significantly alter 
current densities in comparison to the wild-type ion channel. This effect was not due to an 
altered response to magnesium inhibition, nor was TRPM7 transcription perturbed. Instead, 
we found a lack of protein expression in p.G179V and p.T860M transfected cells, alongside 
an increase in p.R494Q protein. Interestingly, inhibiting the 26S proteasome with MG132 
treatment increased p.R494Q expression and inhibited p.T860M expression. To further 
characterise the importance of TRPM7 in developing cardiac myocytes, we measured 
TRPM7 current in hiPSC-derived cardiomyocytes. While we found TRPM7 expression to 
increase in the early stages of differentiation, and there is a large outward TRPM7-like 
current, knockdown with TRPM7 siRNA had no effect on cardiomyocyte action potential 
morphology. 
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Results 
Expressing TRPM7 in HEK293 and CHO-K1 cells 
To ascertain the effect the nonsynonymous mutations may have on TRPM7 function we 
transfected both CHO-K1 and HEK293 cells with a wild-type TRPM7 expression plasmid. 
After 5-10 minutes of dialysis, large outward currents were detected, with an I-V relationship 
typical of TRPM7 (Figure 1A). We analysed outward and inward current at +80mV and -
80mV respectively, in both CHO-K1 and HEK293 cells (Figure 1B-C). Using CHO-K1 cells, 
we demonstrated these currents were susceptible to inhibition to 10mM magnesium (Figure 
1D-F). Current density was also susceptible to inhibition by treatment with 50µM 2-APB 
(Figure 1G-H). HEK293 cell TRPM7 current was also inhibited by treatment with extracellular 
magnesium (data not shown). These data confirmed we had an efficient expression system 
to test the effect of our stillbirth sequenced variants on TRPM7 function. 
Variants alter TRPM7 current density in CHO-K1 and HEK293 cells 
We transfected both cell lines with the four variants of TRPM7 and recorded the current-
voltage relationships. Due to its likely endogenous expression in both cell lines, we found 
TRPM7 I-V relationships in all cells (Figure 2). However when analysing grouped current 
density data we found a significant reduction in current density in CHO-K1 cells when 
transfected with p.G179V (P < 0.05, Figure 2A). We also saw a significant increase in 
current density at both +80mV and -80mV when expressing p.R494Q compared to wild-type 
transfected cells (P < 0.001, Figure 2A). When these experiments were repeated in HEK293 
cells, we found that both p.G179V and p.T860M current density was markedly reduced 
compared to wild-type TRPM7 (P < 0.01 respectively) with a trend to reduction for E1205G 
(Figure 2B). However, in comparison to CHO-K1 expression of p.R494Q, current density 
was equal between wild-type and p.R494Q expressing cells (P = 0.98, Figure 2B).  
Reducing extracellular Mg2+ amplifies difference between wildtype and mutant 
TRPM7 channels 
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We wanted to investigate whether the stillbirth mutations were affecting the TRPM7 
channels response to magnesium inhibition. We perfused transfected CHO-K1 cells with 
extracellular solution supplemented with increasing concentrations of magnesium from 
0.5mM to 6mM after allowing current recordings to plateau. In these experiments, we found 
a significant decrease in current density at +80mV in cells transfected with either p.G179V or 
p.T860M TRPM7 compared to wild-type channels, but only at 0mM Mg2+ (P < 0.01 and 0.05, 
respectively, Figure 3A & C). However, when bath magnesium was increased any difference 
in Mg2+-dependent inhibition between these variants and wild-type TRPM7 was attenuated 
and eventually abolished. Cells expressing p.R494Q TRPM7 showed a significant increase 
in current density at +80mV compared to wild-type cells at both 0mM and 0.5mM Mg2+ (P < 
0.001, Figure 3B). We calculated the IC50 for WT transfected cells at 0.62mM Mg
2+ with a Hill 
coefficient of -1.21. Further analysis of stillbirth variant transfected cell IC50 and Hill 
coefficient values were not significantly different to WT TRPM7 (Supplementary Table 3). 
Interestingly, the inward current for this variant analysed at -80mV was increased compared 
to wild-type TRPM7 at 0mM, 0.5mM and 1mM Mg2+ (P < 0.001, 0.001 and 0.05, 
respectively, Figure 3E). Suggesting that despite physiological levels of magnesium this 
variant increased both inward and outward ionic conductance compared to the wild-type 
TRPM7 channel. These data also suggest that any difference in whole-cell TRPM7 ion 
channel conductance are not the result of a variants influencing the channels response to 
magnesium inhibition, but are more likely due to alterations in expression. 
 In summary, our electrophysiological data show that G179V and T860M result in a 
loss of channel function and R494Q a gain of function which was particularly apparent in 
conditions of low extracellular Mg2+.  
Effect of variants on TRPM7 protein and mRNA expression in heterologous cells 
To investigate whether this decrease in current density was due to altered protein levels, 
whole cell lysates were harvested from transfected cells and western blotting was 
performed. p.G179V and p.T860M TRPM7 mutants did not express well in transiently 
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transfected cells (Figure 4A). Densitometry measurements showed a significant decrease in 
HEK293 cells transfected with either p.G179V or p.T860M TRPM7 compared to WT TRPM7. 
However, when we investigated TRPM7 and mutant mRNA levels in these cells using qPCR, 
the mRNA expression level was similar (Figure 4C). To test whether this reduction in protein 
was due to rapid degradation, we harvested cell lysates after overnight treatment with the 
proteosomal inhibitor MG132. We observed an increase in p.R494Q transfected cells 
compared to wild-type, and we may have able to detect low level expression of p.T860M 
TRPM7 protein (Supplementary Figure 1). 
Confirming the presence of TRPM7 current in hiPSC-derived cardiomyocytes 
We used an in vitro model of cardiomyocyte generation using hiPSC cells to first 
ascertain TRPM7 expression in human cardiac cells, and to test the effect that reduced 
TRPM7 expression may have on the electrophysiological properties of cardiomyocytes. We 
used an in-house hiPSC line (named HS1M) and differentiated the cells into cardiomyocytes 
using a previously published protocol (Supplementary Figure 2)(20). hiPSCs initially 
expressed high levels of TRA-1-60 and three key pluripotency markers which rapidly 
decreased by 7 days of differentiation (20). Individual cells stained positively for cardiac 
troponin T (Figure 5A). We observed variation in TRPM7 expression during differentiation, 
with cardiomyocytes at day 21 expressing more than double that observed in hiPSC cells, 
but this was not significant (Figure 5B). In contrast, pluripotency markers rapidly decreased 
as the cell differentiated (Supplementary Figure 2C). 
 Beating hiPSC-CMs were seeded onto gelatin coated class coverslips at low density 
at days 15-16 for single-cell patch-clamp analysis to detect TRPM7 current at days 21-23. 
We found in all contractile cells subjected to whole-cell patch-clamp, typical TRPM7 currents 
which were detected after dialysis of cells with Mg2+ chelating intracellular solutions. 
Although initial break-in currents were minimal, outward currents at +80mV were detected 
after 5-10 minutes (Figure 5C, E & F). We perfused the bath solution with magnesium to 
confirm these currents were generated by TRPM7 (Figure 5D-F). We found that at both 
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+80mV and -80mV, these currents were susceptible to magnesium inhibition (P < 0.001) 
which could be reversed following washout with standard extracellular solution.  
Mimicking TRPM7 reduction using siRNA does not adversely affect action potential 
parameters in hiPSC-derived cardiomyocytes 
 To mimic possible haploinsufficiency of TRPM7 in developing cardiac cells due to 
p.G179V and p.T860M mutants, we used siRNA to reduce mRNA levels. To patch-clamp 
cells that had taken up TRPM7 siRNA we co-transfected siGLO. Whole-cell patch clamp 
analysis showed markedly reduced outward currents at +80mV (P < 0.001, Figure 6A-B) in 
cells transfected with TRPM7 siRNA. On average this led to a 25.5 pA/pF reduction in 
current density, a similar reduction to that seen in 10mM Mg2+ treated cells (28.1 pA/pF). 
Perhaps due to their small initial size (<5pA/pF), inward currents at -80mV were not 
significantly different between control cells, those perfused with 10mM Mg2+ or those 
transfected with TRPM7 siRNA (Figure 6C). RT-qPCR analysis of these cells found a 
significant decrease in TRPM7 mRNA levels in siRNA transfected populations 
(Supplementary Figure 3). After confirming TRPM7 knockdown, we recorded triggered 
action potentials in a separate set of experiments (Figure 6D-E). To establish whether there 
were any deleterious electrophysiological effects caused by reducing TRPM7 ion channel 
expression we analysed action potential morphology. (Figure 6G-L). We found that there 
were no statistical differences in action potential duration, minimum diastolic potential, 
resting membrane potential and peak voltage amplitude in the action potentials of cells 
transfected with scrambled or TRPM7 targeted siRNA and untransfected cardiomyocytes.  
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Discussion 
Almost half of stillbirths go unexplained, despite extensive post-mortem analysis. In this 
study we present data from previously sequenced and predicted damaging TRPM7 genetic 
variants found in unexplained stillbirth cases (5). There is extensive research studying ion 
channelopathies that cause sudden cardiac death in young adults, however there is little 
evidence of harmful ion channel variants in stillbirth (21). TRPM7 is required for mammalian 
cardiac development, and genetic variation within the gene has been linked to a prolonged 
QT interval (7, 15). To investigate the role these variants may play in perturbing the function 
of the TRPM7 ion channel, we used heterologous expression and hiPSC-CMs to study 
channel function, magnesium response, and expression.   
 Here we show that three TRPM7 variants modify ion channel function in comparison 
to the wild-type channel and identify TRPM7 as an ion channel present in hiPSC-derived 
cardiomyocytes. First, we expressed and characterised the wild-type channel in HEK293 
and CHO-K1 cells before analysing the effects of the four TRPM7 mutants. We report that 
p.G179V and p.T860M variants reduced outward currents significantly compared to the wild-
type channel. Conversely, in a CHO-K1 specific manner, p.R494Q increased observed 
current density at both +80mV and -80mV. This increase remained significantly different 
despite inhibition with 1mM Mg2+.  
Protein expression data confirmed that decreased current density caused by the 
p.G179V and p.T860M variants was due to reduction in protein expression. In the case of 
p.T860M this was at least in part due to rapid proteosomal degradation. It has been shown 
that TRPM7 is required for proper embryonic development and cardiogenesis in mice (15, 
16). Targeted cre-mediated knockdown of TRPM7 before E10 leads to congestive heart 
failure due to lack of myocardial compaction. Later deletion at E12.5 of gestation can lead to 
cardiomyopathy, heart block and impaired repolarisation. Given the experimental data it is 
feasible to postulate that a reduction in TRPM7 function/expression during gestation could 
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have an adverse effect on human cardiac development. Mechanistically it is hard to 
determine the mechanisms that underlie this effect as TRPM7’s role in magnesium and zinc 
homeostasis, alongside control of apoptosis and gene expression is still under investigation 
(10, 12, 13, 22). Reduced TRPM7 expression may limit the cell’s ability to take-up divalent 
cations or hinder their expulsion – alongside adverse changes to a cell’s gene expression 
profile. 
Recent work with cryo-EM microscopy has revealed the closed state structure of mouse 
TRPM7 at the Ångstrom scale (23). These data show several interactions between the N-
terminal domain and the inner plasma membrane, TRP domain or C-terminal domain. Non-
synonymous variants found within these structural motifs may destabilize the protein, 
resulting in misfolding and degradation.  
Using a hiPSC-derived model, we demonstrate that TRPM7 can be found in immature 
human cardiomyocytes 21 days-post differentiation. Analysis of temporal TRPM7 expression 
during cardiomyocyte differentiation showed a gradual increase in mRNA, alongside the 
reduction in pluripotency factors. Single-cell patch-clamp revealed that these cells possess 
relatively large quantities of TRPM7 present at the plasma membrane, with mean outward 
currents of (~33.3 pA/pF). Both treatment with Mg2+ and siRNA transfection significantly 
reduced these currents, strongly suggesting their identity as TRPM7. There is evidence to 
suggest that TRPM7 can regulate cardiomyocyte ion channel gene expression, alongside 
acting as a cation channel in its own right (12, 15, 16). However, when we mimicked 
possible TRPM7 haploinsufficiency we could not detect an effect on action potential 
morphology. This may be due to the temporal aspect indicative of the TRPM7 knockout 
phenotype, shown in mice to vary from lethal to mildly perturbed repolarisation depending 
upon the gestational stage at which TRPM7 is removed. A more severe effect may occur if 
siRNA to TRPM7 was transfected during differentiation, and this an area which warrants 
further in vitro experimentation to identify critical windows of TRPM7 expression during 
hiPSC-derived cardiomyocyte maturation. It is notable that increases in TRPM7 expression 
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occur relatively early in hiPSC cardiac differentiation. It is an open issue whether TRPM7 
currents contribute significantly to the foetal cardiac action potential. Our experiments with 
siRNA suggest that this isn’t the case under physiological ionic conditions, particularly due to 
the inhibitory effect of intracellular Mg2+ present in the tissue. Alternatively, haploinsufficiency 
may have deleterious effects that are not solely related to effects on cardiac excitability but 
to effects on cell survival mediated by the kinase domain.   
In summary, we found two variants in TRPM7, p.G179V and p.T860M reduce ion 
channel current expression, which in the case of p.T860M is likely due to rapid degradation 
mediated by the proteosome. In addition, the p.R494Q TRPM7 variant significantly increases 
TRPM7 ion channel current, in a cell-type specific manner. For the first time we report that a 
TRPM7 current is present in hiPSC-CMs. However, siRNA inhibition at day 15-16, despite 
reducing TRPM7 current, did not alter AP duration. We believe that TRPM7 may play a key 
role in ensuring correct cardiac development of the foetus. TRPM7 is the major Ca2+ channel 
in atrial fibroblasts, and upregulation of these transients is reported in patients with atrial 
fibrillation (24)(24). Significant increases in these Ca2+ influxes from p.R494Q TRPM7 in the 
developing atrial myocardium could predispose developing foetal hearts to atrial fibrillation. 
In a similar fashion a reduction in TRPM7 current may also predispose to cardiac arrhythmia. 
For example it is known that both long and short QT syndromes arising from loss and gain of 
function mutations respectively in KCNQ1 can result in sudden cardiac death in afflicted 
families (25)(25). Therefore, any changes to TRPM7 abundance during early cardiogenesis 
may have severe downstream effects later in gestation, potentially creating a pro-arrhythmic 
cardiac environment. Linking causation with genetic variation is inherently difficult but 
functional assays of potential impairment of protein function can contribute significantly to 
assessing potential pathogenicity (26). Our data indicate inherited or de novo TRPM7 
mutations may increase the risk of unexplained stillbirth and this warrants further attention. 
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Materials and Methods 
Cell culture, plasmids and transfection 
Human Embryonic Kidney-293 cells (HEK293) were a gift from Professor Lily Jan (Howard 
Hughes Medical Institute, San Francisco, USA). Chinese Hamster Ovary-K1 (CHO-K1) cells 
were obtained from the European Collection of Authenticated Cell Cultures (supplied by 
Sigma – 85051005)). HEK293 and CHO-K1 cells were cultured in minimum essential 
medium (31095029, Gibco, ThermoFisher) and Ham’s F12 medium (N6658, Sigma-Aldrich), 
respectively. Both media were supplemented with 10% FBS (10500056, Gibco, 
ThermoFisher) and 100 units/mL of penicillin and 100 µg/mL of streptomycin (15140122, 
Gibco, ThermoFisher).  
A pcDNA4/TO plasmid containing the TRPM7 gene (RefSeq NG_021363.2, NM_017672.6), 
and a tetracycline repressor plasmid, pcDNA6/Tet Repressor were both kind gifts from 
Professor Schmitz (11). An eGFP plasmid (Clontech) was used to identify successfully 
transfected cells. Transfection was carried out using: FuGENE® HD (E2311, Promega) or 
NovaCHOice ® (72622-3, Merck) as per manufacturer’s instructions. Briefly, reactions of 
TRPM7 vector and Tet Repressor plasmid were mixed with the transfection reagent in 37˚C 
Opti-MEM® reduced serum media. After 5-6 hours, transfection complexes were removed 
and fresh media added. Precisely 24 hours later, growth media was changed, this time 
supplemented with 1µg/mL of tetracycline (87128, Sigma-Aldrich). Cells were 
harvested/analysed 24-48 hours after tetracycline induction. 
Patch-clamp electrophysiology 
Whole-cell patch-clamp recordings were made at room temperature (21-25˚C), using 
a multiclamp 700B and digitised using a Digidata 1550B (Molecular Devices). The internal 
pipette contained (in mM): 145-Cs-methanesulfonate (CsSO3CH3), 8 NaCl, 10 HEPES and 
10 EGTA; pH 7.2 with CsOH. The extracellular solution contained (in mM): 145 NaCl, 5 KCl, 
2 CaCl2, 10 Glucose and 10 HEPES (pH 7.4 with NaOH). For measuring TRPM7 current in 
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hiPSC-CMs, the internal pipette solution contained (in mM): 120 L-aspartic acid, 20 CsCl, 
2.5 EGTA, 2.5 EDTA, 10 HEPES, 120 CsOH, 5 Na2GTP (pH 7.2 with CsOH). Extracellular 
solution contained (in mM): 135 NaCl, 5.4 CsCl, 10 HEPES, 10 Glucose, 0.1 CdCl2 and 
1CaCl2 (pH 7.4 with NaOH). To record action potentials, internal pipette solution contained 
(in mM): 110 K-Gluconate, 20 KCl, 10 HEPES, 0.05 EGTA, 0.5 MgCl2, 5 Mg ATP, 0.3 Na2-
GTP and 5 Na2 phosphocreatine (pH 7.4 with KOH). Extracellular solution for action potential 
recordings (mM): 140 NaCL, 2.7 KCl, 1 MgCl2, 2 CaCl2, 0.5 Na2HPO4 and 5 glucose (pH 7.4 
with NaOH). Only cells with membrane resistance >800MΩ and access resistance <10MΩ 
were used in analysis.  
Pipettes were backfilled with intracellular solution to resistance 2 – 3 MΩ. Pipette tips 
were coated with SigmaCote to reduce pipette capacitance (SL2, Sigma-Aldrich). Series 
resistance was set to 70% compensation using the in-built amplifier circuitry. After whole-cell 
configuration was established, recording began immediately to observe current run-up. We 
used a ramp voltage protocol to measure TRPM7 current: the holding potential was set at 
0mV before lowering to -100 mV and then raised to +100 mV over 250 ms before returning 
to 0mV. For time-course analysis experiments this was measured every 5 seconds from 
electrical access being established through the cell. Data was analysed using Clampfit 10.5 
(Molecular Devices).  
In hiPSC derived cardiomyocytes (hiPSC-CMs), we only analysed triggered action 
potentials (APs) from cells which spontaneous action potentials.  APs we triggered using a 
current pulse (between 400-800pA) at a frequency of 1Hz. To calculate action potential 
duration, the time (in ms) was calculated as the time it took for membrane potential to return 
to 50% and 90% (APD50 and APD90) of the resting membrane potential after current trigger. 
Cells were paced for 50 seconds before recording the final 10 action potentials. These 
results of the final 10 traces were combined to give an ‘average’ action potential for every 
cell. We did not analyse cells according to ventricular-like or atrial-like categorisations due to 
a limited number of cells.  
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Protein Harvesting, SDS-PAGE and Western Blotting 
HEK293 cells were transfected at ~70% confluence as previously mentioned and 
harvested 24 hours after tetracycline induction. Cells were washed with PBS+ (0.1mM CaCl2 
and 1mM MgCl2) before a 30-minute incubation on ice with NP-40 lysis buffer containing 
protease inhibitors (11816170001, Sigma-Aldrich). Lysates were scraped into pre-chilled 
tubes and cleared by centrifugation at 10,000 g for 10 minutes at 4˚C. 20µg of protein was 
loaded for each well into 6% polyacrylamide gels. Resolved proteins were transferred to 
PVDF membranes overnight and then blocked for one hour in PBS-T with 5% milk powder or 
1% BSA (A2153, Sigma-Aldrich). Membranes were then incubated with either anti-TRPM7 
(sc-271099, Santa Cruz) or β-actin (ab8226, Abcam) antibodies for one hour at room 
temperature. Secondary antibodies were incubated for one hour at room temperature before 
imaging with Amersham ECL western blotting detection reagent (GE Healthcare). Primary 
and secondary antibody details are listed in supplementary table 1. ImageJ software was 
used to quantify TRPM7 expression which was normalised to loading control β-actin levels, 
and then all stillbirth variant expression was normalised to the WT value in the same gel. For 
proteosomal inhibition experiments, cells were treated with 5µM MG132 (Sigma-Aldrich) for 
16 hours prior to harvesting. 
RNA Harvesting and Quantitative PCR 
Total cell RNA was harvested using a RNeasy mini kit (Qiagen) as per 
manufacturer’s instructions either 24h after tetracycline induction or at specific time points of 
stem cell differentiation. During harvesting of RNA, the column was treated with DNase I for 
15 minutes at room temperature. RNA was diluted in nuclease free water, and 50ng used 
per qPCR reaction. All probes used are listed in Supplementary Table 2. Data was analysed 
using 2-∆∆Ct method normalised to loading control and then normalised to wild-type. To 
calculate gene expression in hiPSC-derived cardiomyocytes, RNA levels were first 
normalised to the housekeeping gene GAPDH. All expression values were then normalised 
to the expression of the gene of interest in naïve iPSC cells prior to differentiation.  
D
ow
nloaded from
 https://academ
ic.oup.com
/hm
g/advance-article-abstract/doi/10.1093/hm
g/ddz198/5551102 by guest on 14 O
ctober 2019
15 
 
Confocal Microscopy 
Cells were first washed with PBS+ to remove media and then fixed with 3.7% 
formaldehyde (Sigma-Aldrich) for 10 minutes at room temperature. Cells were permeabilised 
with PBS Triton X-100 0.1% for 10 minutes. We blocked cells in PBS-T 5% milk for one hour 
and carried out primary anti cTnT incubation for overnight at 4˚C. Fluorescent secondary 
antibody incubation took one hour at room temperature. All antibody details are listed in 
supplementary table 1. Nuclei were counter stained with DAPI and all slides stored at 4˚C 
until imaging with an LSM710 confocal microscope (Zeiss). 
Human Stem Cell-Derived Cardiomyocytes 
Healthy human induced pluripotent stem cell line (named - HS1M) were generated 
and maintained as previously described (27). Cardiomyocytes were differentiated using a 
protocol based upon previous work published by Burridge et al (20). In brief, hiPSCs were 
seeded at 150,000 cells/cm2 in a 24-well plate and allowed to reach ~80% confluence over 
48 hours. Media was changed to ‘CDM3’ (RPMI1640 (Thermofisher) supplemented with 
500µg/ml O.sativa-derived recombinant human albumin (Sigma-Aldrich), 213µg/ml L-
ascorbic acid 2-phosphate (Sigma-Aldrich)) with 6µM CHIR99021 (Sigma-Aldrich). After 48 
hours, media was changed to CDM3 supplemented with 2µM C59 for a further two days 
before regular CDM3 media changes every 2-3 days. For patch-clamp analysis, at 15 days 
post differentiation, cells were treated with TrypLE Express (Thermofisher) for 10 minutes at 
37˚C and seeded onto glass coverslips at a density of 10,000 cells/cm2.  
For TRPM7 siRNA knockdown experiments, 48 hours before patch-clamp analysis, 
adhered cells were transfected with either SMARTpool: ON-TARGETplus TRPM7 targeting 
siRNA or a scrambled control (L-005393-00-0005 or L-006233-00-0005 respectively, 
Dharmacon). DharmaFECT transfection reagent 1, 2.5µL/well (T-2001-02, Dharmacon) was 
used to transfect 2.5µL/well of 2µM siRNA.  
Statistics 
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All data was analysed with GraphPad Prism 6. Grouped data were tested with one-way 
ANOVA, using Dunnett’s multiple comparison to test variants vs wild-type unless otherwise 
stated. For individual analysis of two groups, unpaired t-tests were used to calculate 
statistical differences. When comparing two independent variables, two-way ANOVA with 
Sidak’s multiple comparison test was used. All group data is presented as mean ± S.E.M. 
Significant P values are denoted as * = P < 0.05, ** = P < 0.01 and *** = P < 0.001. 
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Table 1 
 
 
 
 
 
 
 
 
 
 
Table 1. Summary of TRPM7 variants found in stillbirth cases. We sequenced four predicted damaging variants represented 
as both cDNA (c.) and protein (p.) changes. Listed are their relative locations within known domains of the TRPM7 protein. 
GERP++ score estimates the level of functional constraint that DNA position is under, within coding regions the average 
score is conservation score is 2 (28). Polyphen and SIFT scores rate amino acid substitutions on their probability of impacting 
protein structure and function by providing values between 0 and 1 (18, 19). Variants rated above 0.85 by Polyphen are 
confidently predicted to be damaging, while those rated below 0.05 by SIFT are considered likely to be deleterious. 
Mutation taster analyses substitutions based upon base conservation, specific amino acid substitutions, functional domain 
location and other possible splicing effects. All TRPM7 variants were rated as 1 and annotated as disease causing. gnomAD 
frequency represents the variant’s abundance in the online genome aggregation database project, containing 125,748 
exome sequences. 
 
  
Mutation Domain GERP++ PolyPhen 
Mutation 
Taster 
SIFT 
gnomAD 
Frequen
cy 
c.G536T 
p.G179V 
N-terminal 4.65 1 1 0 7.48e-5 
c.G1481A 
p.R494Q 
N-terminal 4.11 1 1 0.21 1.71e-5 
c.C2579T 
p.T860M 
Transmembrane 5.59 1 1 0 7.44e-6 
c.A3614G 
p.E1205G 
C-terminal 5.3 0.561 1 0 1.90e-5 
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Figure 1. TRPM7 current recorded from transfected CHO-K1 and HEK293 cells. A Representative 
TRPM7 current trace from CHO-K1 cell transfected with TRPM7 at initial break-in (t=0s) and after 
current run-up (t=500s). B Current density at +80mV from both CHO-K1 and HEK293 cells transiently 
transfected with TRPM7 (red) compared with untransfected cells (black). C Matching inward current 
density from cells in A, analysed at -80mV. D Whole-cell current trace before (black) and after (red) 
addition of 10mM magnesium to extracellular solution during whole-cell recording of a WT TRPM7 
transfected CHO-K1 cell. E Time course of CHO-K1 whole-cell current showing immediate inhibition 
following 10mM magnesium treatment. F Summary of whole-cell peak current data and following 
10mM magnesium treatment in both WT TRPM7 transfected and UT CHO-K1 cells at +80mV.  G 
Whole-cell current trace before (black) and after (red) addition of 50µM 2-APB to extracellular 
solution during whole-cell recording of a WT TRPM7 transfected CHO-K1 cell.. H Time course of 
current at +80mV from cell shown in (G), showing current reduction over 300seconds following 2-
APB addition. H  WT = wild-type, UT = untransected.  * - P<0.05, *** - P<0.001. 
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Figure 2. Stillbirth TRPM7 variants alter current density in a cell-specific manner. A Summary data 
of average TRPM7 current density at +80mV (red) and -80mV (blue) from CHO-K1 cells (WT n = 28, 
variant n = 13-8). B Summary data of average TRPM7 current density at +80mV (red) and -80mV 
(blue) from CHO-K1 cells (WT n = 24, variant n = 12-7) C Whole-cell current trace recordings from 
CHO-K1 cells transiently transfected with WT, p.G179V, p.R494Q, p.T860M and p.E1205G TRPM7. 
WT = wild-type. * - P<0.05, ** - P <0.01, *** - P<0.001.  
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Figure 3. Stillbirth variants alter TRPM7 current density at low concentrations of magnesium. A-D 
Average TRPM7 current density recorded from transfected CHO-K1 cells at +80mV in response to 
increasing concentrations of bath magnesium (n = 7-8). E Average inward current density (-80mV) of 
cells transfected with p.R494Q TRPM7 F Voltage protocol used throughout these experiments. 
Holding potential was set at 0mV and the protocol repeated every 5 seconds. WT = wild-type, UT = 
untransfected. * = P<0.05, ** = P<0.01, *** = P<0.001 vs WT. 
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Figure 4 Stillbirth variants p.G179V and p.T860M reduce TRPM7 protein levels but leave 
transcription unchanged. A Whole cell lysates from HEK293 cells transiently transfected with wild-
type TRPM7 and mutant vectors. PVDF membranes were initially blotted with anti-TRPM7 before 
stripping and reprobing with anti-β-actin. B Quantification of three western blots from whole-cell 
HEK293 lysates transfected with WT or stillbirth variant TRPM7 normalised to loading β expression 
before normalising to WT expression. C qPCR expression of TRPM7 from transfected cell lysates 
normalized to WT. Lysates were treated with DNase I for 15 minutes at room temperature before 
qPCR analysis. D Whole cell lysates from HEK293 cells treated overnight with 5µM MG132. Cells 
were transfected with wild-type and mutant TRPM7 vectors before overnight incubation with 
proteosomal inhibitor. WT = wild-type, UT = untransfected. *** = P<0.001 vs WT. 
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Figure 5 A TRPM7-like current can be found in 21 day old hiPSC-derived cardiomyocytes. A Staining 
of hiPSC-CMs after 21 days of differentiation for cardiac troponin (cTnT) and DAPI. B  qPCR analysis 
of TRPM7 expression levels over the course of hiPSC-CM differentiation. TRPM7 expression at each 
timpoint was normalized to GAPDH expression before being compared to TRPM7 expression in 
undifferentiated hiPSC cells. C A representative TRPM7 trace from whole-cell hiPSC-CMs. Initial 
current is shown (black) at initial current recordings before magnesium is removed from the bath, 
and a steady plateau is reached (red). D Time course recording of 22 day post-differentiation hiPSC-
CM showing TRPM7 whole-cell current run-up and transient inhibition of 10mM Mg2+ at +80mV (red) 
and -80mV (black). E Paired individual cell current measurements at +80mV peak during extracellular 
solution perfusion, cells were then treated with 10mm Mg2+ over several minutes until current 
plateaued. F Inward current recorded at -80mV in the same cells analysed in D, after current 
stabilisation and after 10mM Mg2+ treatment. * = P<0.05, *** = P<0.001. 
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Figure 6 siRNA mediated knockdown of TRPM7 at day 16 of differentiation does not alter hiPSC-
CM AP parameters. A Comparison of representative TRPM7 currents after run-up in hiPSC-CMs with 
(black) or without TRPM7 siRNA transfection (red). B TRPM7 current measured at +80mV following 
current run-up in non-targeting siRNA treated hiPSC-CMs and the effect of magnesium addition or 
transfection with TRPM7 siRNA. C Inward -80mV current measured from the same cells as in B. D 
Representative action potential trace of non-targeting siRNA treated hiPSC-CMs. E Representative 
action potential trace of hiPSC-CM transfected with siRNA-TRPM7.  F Representative action potential 
trace of hiPSC-CM transfected with siRNA-scrb. G Maximal diastolic potential. H Resting membrane 
potential. I Peak voltage following action potential triggering. J Time to return to RMP or full action 
potential duration in hiPSC CMs. K and L, APD50 and APD90 measurements from the same cells in J. 
All recordings were done in 20-23 day old hiPSC-CMs at room temperature. Scrb = Scrambled. *** = 
P<0.001 vs Control. 
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